Decreased expression of complement 3a receptor (C3aR) in human placentas from severe preeclamptic pregnancies

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 165, Issue 2, 2012, Pages 194-198

  Lim, Ratana ^a,b   Lappas, Martha ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

C3aR; C5aR; Placenta; Preeclampsia

Indexed keywords

COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEX FORMATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST;

EID: 84870295573     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.08.003     Document Type: Article

References (43)

1. W. Ramma, and A. Ahmed Is inflammation the cause of pre-eclampsia? Biochemical Society Transactions 39 2011 1619 1627
2. C.J. Lockwood, S.J. Huang, and G. Krikun Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia Seminars in Thrombosis and Hemostasis 37 2011 158 164
3. A. Conroy, L. Serghides, and C. Finney C5a enhances dysregulated inflammatory and angiogenic responses to malaria in vitro: potential implications for placental malaria PLoS One 4 2009 e4953
4. H.F. Langer, K.-J. Chung, and V.V. Orlova Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis Blood 116 2010 4395 4403
5. T. Monsinjon, P. Gasque, P. Chan, A. Ischenko, J.J. Brady, and M. Fontaine Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells The FASEB Journal 17 2003 1003 1014
6. W.H. Kahr Complement halts angiogenesis gone wild Blood 116 2010 4393 4394
7. W.H. Fischer, M.A. Jagels, and T.E. Hugli Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg) Journal of Immunology 162 1999 453 459
8. X.H. Zhang, Y. Kimura, and C.Y. Fang Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo Blood 110 2007 228 236
9. A.P. Sjoberg, L.A. Trouw, and A.M. Blom Complement activation and inhibition: a delicate balance Trends in Immunology 30 2009 83 90
10. P.F. Zipfel, and C. Skerka Complement regulators and inhibitory proteins Nature Reviews Immunology 9 2009 729 740
11. M.C. Carroll The complement system in regulation of adaptive immunity Nature Immunology 5 2004 981 986
12. S.H. Sacks Complement fragments C3a and C5a: the salt and pepper of the immune response European Journal of Immunology 40 2010 668 670
13. C.G. Cochrane, and H.J. Muller-Eberhard The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement Journal of Experimental Medicine 127 1968 371 386
14. K. Hartmann, B.M. Henz, and S. Kruger-Krasagakes C3a and C5a stimulate chemotaxis of human mast cells Blood 89 1997 2863 2870
15. G. Girardi, J. Berman, and P. Redecha Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome Journal of Clinical Investigation 112 2003 1644 1654
16. E. Soto, R. Romero, and K. Richani Anaphylatoxins in preterm and term labor Journal of Perinatal Medicine 33 2005 306 313
17. E. Soto, R. Romero, and K. Richani Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products Journal of Maternal-Fetal and Neonatal Medicine 23 2010 646 657
18. M. Haeger, A. Bengtson, K. Karlsson, and M. Heideman Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid Obstetrics and Gynecology 73 1989 551 556
19. M. Haeger, M. Unander, and A. Bengtsson Complement activation in relation to development of preeclampsia Obstetrics and Gynecology 78 1991 46 49
20. Z. Derzsy, Z. Prohászka, J. Rigó Jr., G. Füst, and A. Molvarec Activation of the complement system in normal pregnancy and preeclampsia Molecular Immunology 47 2010 1500 1506
21. A.M. Lynch, R.S. Gibbs, J.R. Murphy, P.C. Giclas, J.E. Salmon, and V.M. Holers Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes Obstetrics and Gynecology 117 2011 75 83
22. R.S. Ames, Y. Li, and H.M. Sarau Molecular cloning and characterization of the human anaphylatoxin C3a receptor Journal of Biological Chemistry 271 1996 20231 20234
23. S. Nataf, P.F. Stahel, N. Davoust, and S.R. Barnum Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends in Neurosciences 22 1999 397 402
24. D. Ricklin, G. Hajishengallis, K. Yang, and J.D. Lambris Complement: a key system for immune surveillance and homeostasis Nature Immunology 11 2010 785 797
25. P.A. Ward Functions of C5a receptors Journal of Molecular Medicine (Berlin) 87 2009 375 378
26. M. Lappas, A. Mitton, R. Lim, G. Barker, C. Riley, and M. Permezel SIRT1 is a novel regulator of key pathways of human labor Biology of Reproduction 84 2011 167 178
27. B.P. Morgan, and C.H. Holmes Immunology of reproduction: protecting the placenta Current Biology 10 2000 R381 R383
28. C.H. Holmes, and K.L. Simpson Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship Baillieres Clinical Obstetrics and Gynaecology 6 1992 439 460
29. C.H. Holmes, K.L. Simpson, and S.D. Wainwright Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy Journal of Immunology 144 1990 3099 3105
30. I.U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, and R. DiScipio Complement C3a and C5a induce different signal transduction cascades in endothelial cells Journal of Immunology 169 2002 2102 2110
31. J.M. Roberts, and H.S. Gammill Preeclampsia: recent insights Hypertension 46 2005 1243 1249
32. E. Soto, R. Romero, and K. Richani Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection Journal of Maternal-Fetal and Neonatal Medicine 22 2009 983 992
33. M. Lappas Lower circulating levels of complement split proteins C3a and C4a in maternal plasma of women with gestational diabetes mellitus Diabetic Medicine 28 2011 906 911
34. J. Sonntag, U. Brandenburg, and D. Polzehl Complement system in healthy term newborns: reference values in umbilical cord blood Pediatric and Developmental Pathology 1 1998 131 135
35. P.F. Kohler Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis Journal of Clinical Investigation 52 1973 671 677
36. G. Girardi, D. Yarilin, J.M. Thurman, V.M. Holers, and J.E. Salmon Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction Journal of Experimental Medicine 203 2006 2165 2175
37. V.M. Holers, G. Girardi, and L. Mo Complement C3 activation is required for antiphospholipid antibody-induced fetal loss Journal of Experimental Medicine 195 2002 211 220
38. C.W. Redman, and I.L. Sargent Placental stress and pre-eclampsia: a revised view Placenta 30 Suppl. A 2009 S38 S42
39. S.A. Karumanchi, S.E. Maynard, I.E. Stillman, F.H. Epstein, and V.P. Sukhatme Preeclampsia: a renal perspective Kidney International 67 2005 2101 2113
40. S.E. Wenderfer, H. Wang, B. Ke, R.A. Wetsel, and M.C. Braun C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse Molecular Immunology 46 2009 1397 1404
41. S.E. Wenderfer, B. Ke, T.J. Hollmann, R.A. Wetsel, H.Y. Lan, and M.C. Braun C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice Journal of the American Society of Nephrology 16 2005 3572 3582
42. C. Agostinis, R. Bulla, and C. Tripodo An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development Journal of Immunology 185 2010 4420 4429
43. J. Singh, A. Ahmed, and G. Girardi Role of complement component C1q in the onset of preeclampsia in mice Hypertension 58 2011 716 724